Tue, Sep 2, 2014, 8:06 AM EDT - U.S. Markets open in 1 hr 24 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • nebraskatom01 nebraskatom01 Oct 22, 2013 3:38 PM Flag

    Back in with trading shares.....10K shares at 16.30-16.33

    fully loaded again, all the comps will be positive for earnings call......for a long time coming....IMO

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Almost sold these shares today for 17.80........decided to hold them for 19 ish.........probably a mistake but I feel the revisions upward are going to put us there in next couple weeks. IMO it is time to buy.....

      Sentiment: Strong Buy

    • so far, so good looks like IMGN wants to hold up and test $17 again soon.

      After reading the comments about preparing for another DJ CC debacle I sent IMGN a message suggesting they do some prep work prior to the cc to avoid repeating the recent poor performances. Let's see how it goes. They usually do well leading up to the cc and then an analyst asks a somewhat challenging question and they provide a weak, weasely answer that says nothing, then we get more about delay, nothing tangible about progress, lots of promises about the future, they use a word that should be banned "monetization" (it's worse than saying shank to a golfer...sorry). Hopefully, Dan will say I am the new CFO and the BOD is looking for a new CEO, but I doubt it.

      From the IV board recently, 289 study has commenced and Roche started another very large 2500-patient Kadcyla + Perjeta study. People may think that Kad sales started off slow, but Roche is making a massive investment in Kad trials, they must think Kad can produce $millions in annual revs based on the trials in which they are investing.

 
IMGN
11.82+0.16(+1.37%)Aug 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Conns Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT